Difference between revisions of "Vimentin"

Jump to navigation Jump to search
957 bytes added ,  01:21, 3 August 2016
Line 5: Line 5:
*Most [[sarcoma]]s.
*Most [[sarcoma]]s.
*[[Malignant melanoma]].<ref name=pmid27052289>{{Cite journal  | last1 = Mısır | first1 = AF. | last2 = Durmuşlar | first2 = MC. | last3 = Zerener | first3 = T. | last4 = Gün | first4 = BD. | title = Primary malignant melanoma. | journal = Saudi Med J | volume = 37 | issue = 4 | pages = 446-9 | month = Apr | year = 2016 | doi = 10.15537/smj.2016.4.15017 | PMID = 27052289 }}</ref>
*[[Malignant melanoma]].<ref name=pmid27052289>{{Cite journal  | last1 = Mısır | first1 = AF. | last2 = Durmuşlar | first2 = MC. | last3 = Zerener | first3 = T. | last4 = Gün | first4 = BD. | title = Primary malignant melanoma. | journal = Saudi Med J | volume = 37 | issue = 4 | pages = 446-9 | month = Apr | year = 2016 | doi = 10.15537/smj.2016.4.15017 | PMID = 27052289 }}</ref>
*[[Lymphoma]]s - many.<ref name=pmid2524200>{{Cite journal  | last1 = Domagala | first1 = W. | last2 = Lasota | first2 = J. | last3 = Chosia | first3 = M. | last4 = Weber | first4 = K. | last5 = Osborn | first5 = M. | title = Leukocyte-common antigen and vimentin are reliable adjuncts in the diagnosis of non-Hodgkin's lymphoma in fine needle aspirates. | journal = Anal Quant Cytol Histol | volume = 11 | issue = 1 | pages = 15-21 | month = Feb | year = 1989 | doi =  | PMID = 2524200 }}</ref><ref name=pmid1711289>{{Cite journal  | last1 = Gustmann | first1 = C. | last2 = Altmannsberger | first2 = M. | last3 = Osborn | first3 = M. | last4 = Griesser | first4 = H. | last5 = Feller | first5 = AC. | title = Cytokeratin expression and vimentin content in large cell anaplastic lymphomas and other non-Hodgkin's lymphomas. | journal = Am J Pathol | volume = 138 | issue = 6 | pages = 1413-22 | month = Jun | year = 1991 | doi =  | PMID = 1711289 }}</ref>


===Vimentin and cytokeratin positivity===
===Vimentin and cytokeratin positivity===
48,536

edits

Navigation menu